Latest United States Startup Funding Rounds
Startup funding in United States: recent rounds, the companies behind them and their participating investors.
- Rounds
- 2,130 Jan 1 – Oct 9, 2026
- Disclosed funding
- $200B 1764 disclosed amounts
- Median round
- $24M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| A Provides AI system for professional sports businesses to automate operations | $6M | Pre-SeedPre-seed | Consumer | United States | Investors | |
| I Provides AI-driven medical professional liability insurance | $50M | Undisclosed | Fintech | United States | Investors | |
| TT Develops treatments to rejuvenate vision in the aging eye | $235M | Series B | Biotech | United States | Investors | |
| N Develops mission-specific AI applications on the Palantir operating system | $22M | Series A | Enterprise software | United States | Investors | |
| T TalosCompany profile Provides institutional-grade technology and data for digital asset investment lifecycle Provides institutional-grade technology and data for digital asset investment lifecycle | $45M | Series B+Series B | Fintech | United States | Investors | |
| BR Branded RealitiesCompany profile Creates personalized fan experiences for pro and college sports using AR/AI Creates personalized fan experiences for pro and college sports using AR/AI | $1.6M | Seed | Consumer | United States | Investors Undisclosed | |
| PC PranaX CorporationCompany profile Develops exosome-based technologies for regenerative biologics and wellness Develops exosome-based technologies for regenerative biologics and wellness | $17M | Series A | Biotech | United States | Investors Undisclosed | |
| P PrenosisCompany profile Develops integrated diagnostics and therapeutics for critical care conditions Develops integrated diagnostics and therapeutics for critical care conditions | $20M | Series A | Biotech | United States | Investors | |
| P Develops AI meta-system to enhance LLMs for problem-solving | $45.8M | Seed | AI | United States | Investors | |
| ET Elysium TherapeuticsCompany profile Develops treatments to prevent and reverse overdoses caused by synthetic opioids Develops treatments to prevent and reverse overdoses caused by synthetic opioids | $7.5M | SAFEUndisclosed | Biotech | United States | Investors Undisclosed |
Active investors in this selection
All investors →Ranked by rounds participated in · From Jan 1, 2026
- 1Y Combinator (YC)
Nous Research, Santé, Vitalize
125rounds3led - 2Andreessen Horowitz (a16z)
TypeSafe AI, Arena, Vesta
94rounds18led - 3General Catalyst
Minerva Humanoids, Melius
65rounds6led - 4Alumni Ventures
Savvy Wealth, Mona, American Supercritical
55rounds0led - 5Khosla Ventures
Arena, Vinci, Conway Research
54rounds5led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.